+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 115 Pages
  • United States
From
SOLIRIS Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SOLIRIS Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Ulcerative Colitis (UC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 147 Pages
  • Global
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
From
COSENTYX Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

COSENTYX Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
ENSPRYNG Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENSPRYNG Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
From
Androgenetic Alopecia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Androgenetic Alopecia - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 67 Pages
  • Global
From
RINVOQ Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RINVOQ Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
REMICADE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ENBREL Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENBREL Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
KEVZARA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEVZARA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ACTEMRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ACTEMRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SIMPONI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
RITUXAN Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RITUXAN Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ORENCIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ORENCIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more